Research suggests need for long-term follow-up for patients with Kawasaki Disease

9 Sep 2015, 4:57 p.m.

Image of Paul Brogan

Kawasaki disease is a rare condition that causes blood vessels to become inflamed and swollen. It predominantly occurs in children under the age of five. If left untreated, it results in balloon-like swellings (aneurysms) in the coronary vessels of approximately 25% of cases. To date, the cause of this disease remains unknown. A group of researchers led by Dr Paul Brogan recently conducted a study aiming to shed light on how the disease develops. Ninety-two children with KD were examined at the Somers Clinical Research Facility (CRF) at GOSH. Levels of circulating endothelial cells (CECs), which are mature cells that have become detached from the vessel wall and are often associated with vascular injury, were measured years after patients developed KD.

The researchers found CECs were elevated in KD patients, usually highest in patients with coronary artery aneurysms. Elevated levels of CECs were also seen in some KD patients that had not had coronary artery aneurysms. While the relevance of elevated CECs are not yet known, this study provides rationale for long-term follow up of these patients.

This study has been accepted for publication in the journal, Heart. It was conducted at the BRC-supported Somers CRF at GOSH. Dr Brogan is a BRC-supported researcher.

GOSH contributes to landmark UAE-UK paper on AI in healthcare

We're proud to have contributed to a new paper published by the UAE-UK Business Council, exploring future opportunities for collaboration in artificial intelligence (AI) in healthcare between the United Kingdom and the United Arab Emirates.

Landmark gene therapy study shows safety for children

Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.

New study pinpoints why some transplanted kidneys are rejected

Researchers at University College London (UCL), the Wellcome Sanger Institute and the University of Cambridge combined technology that determines the genetic or RNA sequence of individual cells with powerful 3D imaging to look at lymphatic vessels

Scientists discover clues to help children with rare muscle disease

New ground-breaking research by experts at Great Ormond Street Hospital (GOSH) and University College London (UCL) has led to an exciting discovery that could help children with the rare muscle disease, juvenile dermatomyositis (JDM).